Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Equity Average (2016 - 2020)

Historic Equity Average for Glucotrack (GCTK) over the last 7 years, with Q3 2020 value amounting to $10.2 million.

  • Glucotrack's Equity Average rose 250351.7% to $10.2 million in Q3 2020 from the same period last year, while for Sep 2020 it was $10.2 million, marking a year-over-year increase of 250351.7%. This contributed to the annual value of -$2.1 million for FY2019, which is 7796.56% up from last year.
  • According to the latest figures from Q3 2020, Glucotrack's Equity Average is $10.2 million, which was up 250351.7% from $10.7 million recorded in Q2 2020.
  • Glucotrack's Equity Average's 5-year high stood at $10.7 million during Q2 2020, with a 5-year trough of -$16.6 million in Q2 2018.
  • Over the past 5 years, Glucotrack's median Equity Average value was -$9.9 million (recorded in 2016), while the average stood at -$6.5 million.
  • Its Equity Average has fluctuated over the past 5 years, first plummeted by 6546.63% in 2016, then soared by 250351.7% in 2020.
  • Quarter analysis of 5 years shows Glucotrack's Equity Average stood at -$10.4 million in 2016, then crashed by 50.42% to -$15.7 million in 2017, then soared by 39.94% to -$9.4 million in 2018, then surged by 87.94% to -$1.1 million in 2019, then soared by 995.41% to $10.2 million in 2020.
  • Its Equity Average stands at $10.2 million for Q3 2020, versus $10.7 million for Q2 2020 and $4.8 million for Q1 2020.